<SEC-DOCUMENT>0001104659-21-074024.txt : 20210528
<SEC-HEADER>0001104659-21-074024.hdr.sgml : 20210528
<ACCEPTANCE-DATETIME>20210528151917
ACCESSION NUMBER:		0001104659-21-074024
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210528
DATE AS OF CHANGE:		20210528

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		21979722

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm2117944d1_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
STATES<BR>
</B></FONT><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
of<BR>
the Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by the Registrant&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings">x</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by a Party other than the Registrant</FONT>&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material under &sect;240.14a-12</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>UnitedHealth Group Incorporated</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Registrant as Specified In Its Charter)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Filing Fee (Check the appropriate box):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt; width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate number of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed maximum aggregate value of transaction:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total fee paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">o</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount Previously Paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form, Schedule or Registration Statement No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Party:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date Filed:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 0.7pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2117944d1_defa14aimg001.jpg" ALT="" STYLE="height: 26px; width: 350px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UnitedHealth Group Incorporated Supplemental
Proxy Materials<BR>
For the Annual Meeting of Shareholders on June 7, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 28, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear UnitedHealth Group Shareholders,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By now you should have received UnitedHealth Group&rsquo;s (UHG) Proxy
Statement (the &ldquo;Proxy Statement&rdquo;), along with the proxy card or notice of Internet availability of proxy materials. The UHG
virtual annual meeting of shareholders occurs on June 7, 2021. We have asked for your support of the Board&rsquo;s recommendations on
the proposals to be voted on at the meeting. In this letter, we wish to specifically focus on the proposal regarding the company&rsquo;s
executive compensation approach (Say on Pay proposal), given the conflicting recommendations on that proposal from two proxy advisory
firms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One proxy advisory firm, Glass Lewis, has recommended shareholders
vote &ldquo;FOR&rdquo; the company&rsquo;s Say on Pay proposal, while another proxy advisory firm, Institutional Shareholder Services
(&ldquo;ISS&rdquo;), is opposing the Say on Pay proposal. ISS has not expressed any concerns about the company&rsquo;s overall executive
compensation program. To the contrary, ISS concluded UHG&rsquo;s &ldquo;pay and performance are reasonably aligned at this time<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>.&rdquo;
This conclusion is consistent with ISS&rsquo;s view of the company&rsquo;s approach to executive compensation for the last several years;
an approach that has resulted in a rigorous and effective compensation plan governed by the Compensation and Human Resources Committee
of our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board believes that the steady approach to executive compensation
over the years has been a critical factor in the company&rsquo;s outstanding performance. It has enabled the company to shape its business
platforms and long-term strategy to deliver higher quality health care to the people it serves, while rewarding UHG&rsquo;s investors
with consistent, sustainable growth and returns. The company&rsquo;s compensation plan is designed to help UHG achieve its long-range
strategy by closely aligning executives&rsquo; compensation with achievement of UHG&rsquo;s business goals and mission and preservation
of its culture. Approximately 75% of senior executive compensation is delivered as UHG equity, with one-half of equity awards conveyed
through long-term performance-based shares. Using equity as the large majority of management&rsquo;s compensation opportunity directly
connects the company&rsquo;s executives to the returns generated for shareholders. Importantly, the compensation program is an integral
part of the company&rsquo;s efforts to attract, retain and recruit highly qualified talent necessary to lead a diverse, broad-based health
care company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP></SUP></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP>ISS Proxy Analysis &amp; Benchmark Policy Voting Recommendations.,
UnitedHealth Group Incorporated.&copy; 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each year, the Compensation Committee&rsquo;s independent review includes
an independent compensation consultant who conducts a pay for performance analysis that compares UHG&rsquo;s total shareholder return
relative to peer companies as well as the realizable pay for UHG&rsquo;s most senior executives. This analysis has consistently shown
UHG&rsquo;s senior executive compensation is strongly aligned to the total return to shareholders, a conclusion consistent with both ISS
and Glass Lewis. The company&rsquo;s compensation approach has also enabled UHG to successfully deliver on its mission to help people
live healthier lives and help the health system work better for all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ISS&rsquo;s opposition is based on compensation to David Wichmann in
connection with his transition from his role as UHG&rsquo;s CEO. This compensation, after more than two decades of service to the company,
has no bearing on the nature or effectiveness of the company&rsquo;s long-standing and continuing approach to executive compensation which
deserves shareholders&rsquo; support again this year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Wichmann&rsquo;s successful tenure as CEO focused on business growth
and innovation, strategic capital deployment and significant advances in the Company&rsquo;s net promoter score and employee satisfaction.
His tenure included navigating the company through the complex operational challenges of the COVID-19 pandemic. During Mr. Wichmann&rsquo;s
lengthy career at UHG, he helped shape the company&rsquo;s business platforms and its long-term strategy to deliver higher quality health
care and produce sustainable returns to shareholders. In the last twenty years, UHG revenues have grown at a compound rate of 13% per
year, and earnings per share have grown 20% annually. Over the last twenty years, UHG stock has provided an average annual total shareholder
return in excess of 20%. Mr. Wichmann&rsquo;s compensation awarded at the time of his transition reflects what he is entitled to under
his contract. A contract that also includes non-compete and non-solicit obligations, which provide significant value to UHG&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We appreciate your support by voting in accordance with the recommendations
of our Board of Directors on all proposals, including &ldquo;For&rdquo; approval of UHG&rsquo;s named executives&rsquo; pay under the
company&rsquo;s annual Say on Pay proposal (Management proposal No. 2). We encourage you to please evaluate the company&rsquo;s executive
compensation program as a whole, including how it has delivered long-term, exceptional financial returns for UHG shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Even if you have already voted, you can change your vote at any time
before the 2021 Annual Meeting, as described in more detail in UHG&rsquo;s Proxy Statement. If you have any questions or require assistance
in voting your shares or changing your vote, please contact the company&rsquo;s proxy solicitor, Morrow Sodali LLC at 470 West Avenue,
Stamford, CT 06902. Stockholders may call: (800) 662-5200. Banks and brokers may call (203)&nbsp;658&#45;9400. UHG&rsquo;s Proxy Statement,
this supplemental proxy material and Annual Report, are available at <U>www.unitedhealthgroup.com/proxymaterials</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2117944d1_defa14aimg02.jpg" ALT="" STYLE="width: 180px; height: 44px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Timothy P. Flynn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chair, Compensation &amp; Human Resources Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2117944d1_defa14aimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2117944d1_defa14aimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G @\# 2(  A$! Q$!_\0
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M)K T3QWX=\1:A]ATV^,MQM+A&B=,@=<$@5?\2?\ (KZM_P!><W_H!KPKX/\
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M,-X87SQAN5_F:^G*Z,3\2,:&S/-?C;_R)]I_U_+_ .@/1\$_^1.N_P#K^?\
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M_P#H)KP?X=:G)X?^(%HEP&B$KFSG5N""QP ?HP7\J]X\9_\ (DZW_P!>4O\
MZ":RK1M43[FE-WA8\:^"_P#R/$O_ %Y2?^A)7T#7S]\%_P#D>)?^O*3_ -"2
MOH&EB?C"C\ 5\Y_%W_DH5W_URB_] %?1E?.?Q=_Y*%=_]<HO_0!3PWQA7^$]
M[T#_ )%S3/\ KTB_] %7;C_CVE_W#_*J6@?\BYIG_7I%_P"@"KMQ_P >TO\
MN'^58/<U6Q\IZ%JUUH?B*#4K.%)KB!V*1N"0<@CH.>]>@?\ "X?%?_0$L_\
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'+"BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2117944d1_defa14aimg02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2117944d1_defa14aimg02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  Z 0(# 2(  A$! Q$!_\0
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M/Q]^V!\0-3M?$7Q0_:!UBZ)N4D$O]DZ?!.R?9EY.S,B?<_ACA@7C%?/]M>_
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M*-U!+\!OV/K\Z]XGO'_X]-<\7")C!:AC\K)81;I9.>)'52/3YQ_9'^).I?\
M!5+XV?$SX@Z3>RIXC^/5S/X/\/74+'S/ /PUL+AHKN[RH4P7.H7 EBBRVXR$
MNN5@<#B])_X)9_&C_@CU_P $3_VK=9^(7Q2U'QIXI\0:%<VMAH^A>(]2N_#^
MDV]VZ1W=YY-PL*M=R^;(SRF+*B,88EFKZM_X(ZO\%O\ @F__ ,$@?A+XA\/-
M)KVN_%#2K2]%KI[I>:YXOUN:+<VGVJ97)B<R1A"5C@5'>1D D>M:,:<%*_O*
M$8W\YU;N6G72"AWY+T];\R)SG*S@N5RD[.]K0II6_P#)I<^MES+GV7*>M?\
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MJ+WOAV#6;&.VL-% ?=$[P*SBXN$X_>N0FX!EB1@"/U'HK15)*L\0G[[Z]?\
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@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
